Literatur
Cooper R (2014) On deciding to have a lobotomy: Either lobotomies were justified or decisions under risk should not always seek to maximise expected utility. Med Health Care Philos 17:143–154
Karha J, Topol EJ (2004) The sad story of Vioxx, and what we should learn from it. Cleve Clin J Med 71:933–934 (936, 938–939)
Lerner BH (2005) Last-ditch medical therapy – revisiting lobotomy. N Engl J Med 353:119–121
Mcculloch P, Altman DG, Campbell WB et al (2009) No surgical innovation without evaluation: The IDEAL Recommendations. Lancet 374:1105–1112
Neugebauer E, Troidl H, Spangenberger W et al (1991) Conventional versus laparoscopic cholecystectomy and the randomized controlled trial. Cholecystectomy Study Group. Br J Surg 78:150–154
Rogers EM (2010) Diffusion of innovations. Simon and Schuster, New York
Schrader P (2005) Technique evaluation for orthopedic use of Robodoc. Z Orthop Ihre Grenzgeb 143:329–336
Trentzsch H, Piltz S, Tager G et al (2009) Randomized clinical trials in trauma surgery: Decision-making in an area of conflict between eminence and evidence. Unfallchirurg 112:742–748
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
D. Pieper und E. Neugebauer geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Pieper, D., Neugebauer, E. Chirurgische Innovationen brauchen die Überprüfung in kontrollierten klinischen Studien. Chirurg 87, 976–977 (2016). https://doi.org/10.1007/s00104-016-0304-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-016-0304-0